Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Bowel cancer - key knowledge points on screening For general practitioners Benefits of screening Current screening participation rate Bowel cancer screening by faecal occult blood testing (FOBT) reduces deaths from bowel cancer through early detection. At present, the National Bowel Cancer Screening Program (NBCSP) offers free FOBTs at 50, 55, 60, 65, 70 and 74 years of age. Biennial screening for all people aged 50-74 will be fully implemented by the NBSCP by 2020. In NSW current screening participation rate is low, with 33% of people invited to the NBCSP completing the test. Bowel cancer, mortality, by extent of disease at diagnosis, NSW, 2010 10 50% Deaths per 100,000 8 9.07 36% 33 NSW NBCSP screening participation rate 7.09 6 Notes: • Source: NSW Cancer Registry • Mortality has been age-standardised to the Australian 2001 standard population. • 'Unknown' extent of disease is not shown. 4 2 0 2.58 Localised Regionalised % Distant Extent of disease at diagnosis Mortality increases with more advanced disease. Compared with localised disease, the risk of death is 2.7 times higher in regionalised disease and 3.5 times higher in distant disease. However, only 31% of bowel cancers in NSW are diagnosed at the localised stage.* Population screening by FOBT can: Bowel screening participation rate is based on the proportion of the eligible population invited to the NBCSP from July 2013 to June 2014, who returned a completed faecal occult blood test (FOBT). Source: NBCSP. If bowel screening participation rates increased to 60% in NSW and across Australia, up to Increase the proportion of bowel cancers diagnosed at the localised stage. Prevent bowel cancer by detecting pre-cancerous lesions. 90,000 lives could be saved from bowel cancer over the next 40 years.1 Click on the links below for more information on: The NBCSP Role of GPs in the NBCSP Clinical guidelines Working together to lessen the impact of cancer Practice tips safe non-invasive FOBT is a and test that people can easily self-administer 92 % of people state they would be more likely to participate in bowel screening if recommended by their doctor.† Ensure all eligible people are screened appropriately. * Based on NSW incidence 2010 † Based on a Newspoll telephone survey of 667 NSW residents aged 18+ in May 2015. 1. Cenin DR, St John J, Slevin T et al. Optimising the expansion of the National Bowel Cancer Screening Program. Med J Aust 2014;201:456-61. cancerinstitute.org.au/bowel-cancer